Catalyst Pharmaceuticals Inc (CPRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CPRX Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Catalyst Pharmaceuticals Inc finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent755.86
Cash & Short-term Investments755.00
Accounts receivable130.83
Inventories34.93
Other Current Assets0.00
Prepaid Expense And Other Assets Current18.77
Total Current Assets940.39
Equipment/Property/Plant Net0.99
Intangible Assets121.97
Other Assets, Noncurrent84.26
Operating Lease Right Of Use Asset1.86
Total Assets1,147.61
Liabilities
Accounts Payable, Current AC7.15
Accrued Liabilities, Current AC125.25
Other Liabilities, Current0.00
Total Current Liabilities132.40
Total Long-term Debt0.00
Other liabilities, Noncurrent2.52
OperatingLeaseLiabilityNoncurrent2.24
Total Liabilities134.91
Stockholders' Equity
Common Stock Value0.12
Additional Paid In Capital Common Stock489.22
Retained Earnings / Accumulated Deficit523.35
Other Equity0.01
Common Stockholder's Equity1,012.70
Total Stockholder's Equity1,012.70
Liabilities & Stockholder's Equity1,147.61
4 historic quarters locked

Sign in to unlock the full Catalyst Pharmaceuticals Inc balance sheet history.

About Catalyst Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001369568-26-000002

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.